Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DARIDOREXANT vs DASATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DARIDOREXANT vs DASATINIB: Safety Overview

Metric DARIDOREXANT DASATINIB
Total FAERS Reports 2,016 30,019
Deaths Reported 38 2,681
Death Rate 1.9% 8.9%
Hospitalizations 77 6,437
Average Patient Age 59.4 yrs 56.4 yrs
% Female Patients 65.1% 51.9%
FDA Approval Date Apr 7, 2022 Apr 22, 2025
Manufacturer N/A Zydus Pharmaceuticals USA Inc.
Route N/A ORAL
Marketing Status Prescription Prescription